Ares Commercial Real Estate has renewed loan originations and expanded funding capacity, but Q1 2026 still showed a GAAP loss, a large CECL reserve, non-accrual CRE loans, and a dividend that needs stronger recurring earnings support.
References
Sources used in this report
SEC APISEC submissions JSON2026-05-13 · Company identity, CIK, ticker, exchange, filing sequence, and headquarters.SEC APISEC companyfacts JSON2026-05-13 · XBRL financial fact cross-check support.SEC filingQ1 2026 Form 10-Q2026-05-07 · Latest financial statements, portfolio, non-accrual loans, loans held for sale, financing, covenants, REIT rules, and risk disclosures.SEC-filed releaseQ1 2026 earnings release2026-05-07 · Q1 GAAP and Distributable Earnings, dividend, new loan commitments, and management commentary.SEC-filed presentationQ1 2026 earnings presentation2026-05-07 · Book value, CECL reserve, portfolio mix, risk-rated loans, funding capacity, balance sheet, income statement, and DE reconciliation.SEC filingFY2025 Form 10-K2026-02-10 · Annual business model, risk factors, external manager, REIT status, related-party framework, and annual financials.SEC-filed releaseFY2025 results release2026-02-10 · FY2025 and Q4 results, repayments, risk-rated loan cleanup commentary, and resumed investment activity.SEC-filed presentationFY2025 earnings presentation2026-02-10 · FY2025 balance sheet, portfolio baseline, financial bridge, and risk/reward framing.SEC filing2026 proxy statement2026-04-01 · Annual meeting, board nominees, director independence, auditor ratification, management agreement, fees, reimbursements, co-investments, and related-party disclosures.SEC filingMorgan Stanley facility amendment 8-K2026-03-24 · Secured funding amendment context and borrowing-capacity support.